التفاصيل البيبلوغرافية
| العنوان: |
SARS-CoV-2 and bioimmunotherapy for ulcerative colitis. |
| المؤلفون: |
KANG Yin-nan, JIE You-cheng, LIU Shan-shan, WANG Jun-ke, LI Chu-yi, YU Xiao-hui, ZHANG Jiu-cong |
| المصدر: |
Journal of Hainan Medical University; Aug2022, Vol. 28 Issue 16, p1-5, 5p |
| مستخلص: |
Novel coronavirus (SARS-CoV-2, SARS-CoV-2 for short) infection can cause a series of gastrointestinal damage. Related studies have reported that SARS-CoV-2 infection can lead to the occurrence and progression of ulcerative colitis, which may be related to the cytokine storm caused by SARS-CoV-2 infection. Recently, we have also paid attention to whether infection with SARS-CoV-2 will aggravate the condition of UC patients receiving biological immunotherapy and whether vaccination with SARS-CoV-2 is safe and effective for these patients. At present, the interaction mechanism between SARS-CoV-2, SARS-CoV-2 vaccine and ulcerative colitis is not fully understood, and more research is needed to further clarify the relationship. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Hainan Medical University is the property of Journal of Hainan Medical College Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
